The revised Annex 1 is longer and more prescriptive than the version it replaced, but its organising idea is one word: strategy. Every site making sterile products is expected to have a contamination control strategy (CCS) — a documented, site-wide set of controls, derived from current product and process understanding, that addresses every potential source of microbial, particulate and endotoxin or pyrogen contamination, and is reviewed for effectiveness. Quality risk management runs through the whole annex as the way decisions are justified.
The areas the annex covers
- Pharmaceutical quality system and the contamination control strategy, kept current and periodically reviewed.
- Premises and cleanroom grades A to D, with qualification, barrier technologies, airflow and disinfection.
- Utilities — water systems including water for injection, steam used as a direct sterilant, gases and vacuum, with monitoring against alert and action limits.
- Personnel — training and qualification, and a gowning qualification programme with periodic reassessment.
- Production and specific technologies — terminal sterilisation, moist heat, dry heat and other sterilisation methods, sterile filtration with filter integrity testing, lyophilisation, closure integrity and finishing.
- Environmental and process monitoring — viable and non-viable monitoring against alert and action limits, with trending and excursion investigation.
- Aseptic process simulation — media fills that represent the routine process, with defined frequency, acceptance and response to failure.
- Quality control — including the requirement for filled containers of parenterals to be inspected individually for extraneous contamination or defects.
For a sterile site, the practical consequence is evidence. An inspector following a batch will expect to see that every aseptic step happened in a qualified room, without an open excursion, by a qualified operator, on a line with a current media fill — and that every sterilisation cycle, filter test, integrity test and inspection result behind the release decision is recorded and reviewed.
